A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects

Trial Profile

A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jun 2016

At a glance

  • Drugs Nafithromycin (Primary)
  • Indications Community-acquired pneumonia
  • Focus Pharmacokinetics
  • Sponsors Wockhardt
  • Most Recent Events

    • 31 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 01 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top